Division of Biochemistry and Center for Biomedical Genetics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5590-5. doi: 10.1073/pnas.1017516108. Epub 2011 Mar 21.
In ubiquitin conjugation, different combinations of E2 and E3 enzymes catalyse either monoubiquitination or ubiquitin chain formation. The E2/E3 complex Rad6/Rad18 exclusively monoubiquitinates the proliferating cell nuclear antigen (PCNA) to signal for "error prone" DNA damage tolerance, whereas a different set of conjugation enzymes is required for ubiquitin chain formation on PCNA. Here we show that human E2 enzyme Rad6b is intrinsically capable of catalyzing ubiquitin chain formation. This activity is prevented during PCNA ubiquitination by the interaction of Rad6 with E3 enzyme Rad18. Using NMR and X-ray crystallography we show that the R6BD of Rad18 inhibits this activity by competing with ubiquitin for a noncovalent "backside" binding site on Rad6. Our findings provide mechanistic insights into how E3 enzymes can regulate the ubiquitin conjugation process.
在泛素缀合中,不同的 E2 和 E3 酶组合催化单泛素化或泛素链形成。E2/E3 复合物 Rad6/Rad18 专门将增殖细胞核抗原 (PCNA) 单泛素化,以发出“易错”DNA 损伤耐受信号,而在 PCNA 上形成泛素链则需要另一套缀合酶。在这里,我们表明人 E2 酶 Rad6b 具有内在催化泛素链形成的能力。这种活性在 PCNA 泛素化过程中被 Rad6 与 E3 酶 Rad18 的相互作用所阻止。我们使用 NMR 和 X 射线晶体学表明,Rad18 的 R6BD 通过与泛素竞争非共价“背面”结合位点来抑制这种活性Rad6。我们的研究结果为 E3 酶如何调节泛素缀合过程提供了机制见解。